Table 4.
Univariate Hazard Ratio | 95% CI | P value | Multivariate Hazard Ratiod | 95% CI | P value | |
---|---|---|---|---|---|---|
Relapse (n = 65) | 10.12 | (3.58, 28.98) | <0.0001 | 11.76 | (1.97, 19.76) | <0.002 |
Complete Remission | 0.77 | (0.16, 3.58) | 0.73 | |||
Treatment Resistance | 6.25 | (1.97, 19.76) | <0.002 | 5.46 | (1.34, 22.2) | <0.018 |
Age <16 | 1.13 | (0.41, 3.14) | 0.81 | |||
African American | 1.17 | (0.40, 3.46) | 0.30 | |||
BMI Z-score | 1.08 | (0.76, 1.56) | 0.64 | |||
Baseline GFRa | 0.88 | (0.76, 1.03) | 0.10 | |||
Proteinuriab | 1.04 | (0.90, 1.19) | 0.62 | |||
Hypertension | 0.99 | (0.33, 3.01) | 0.99 | |||
Class IV nephritis | 1.36 | (0.38, 4.86) | 0.63 | |||
Cyclophosphamide | 1.64 | (0.37, 7.35) | 0.51 |
Change in eGFR by 10 ml/min/1.732.
Change in proteinuria by 1 g/d.
n = 73 unless otherwise specified.
Estimate adjusted for African American ethnicity and baseline eGFR.